I am super honored to co-author a commentary on Inflammasomes and Pyroptosis as Therapeutic Targets for COVID-19 with @VirusesImmunity and @MiyuMoriyama from @YaleMed. Here's to effective therapies and vaccines!
https://t.co/DFHSsOMKkq
This time, we developed a nasal booster vaccine for influenza viruses. In this preprint, @MiyuMoriyama et al. show that nasal boosters with unadjuvanted hemagglutinin protein induce sterilizing immunity in mice against flu. (1/)
https://t.co/JYkm9h6xeR
It is out! 🚨 Phosphorous-free bacterial lipids can switch between pro- and anti-inflammatory depending on context!🔬 #Immunology#LipidBiology@PelegrinPablo@inflammasomelab
A big thanks to the reviewers and editors. It was a laborious but smooth process🥳
2-years after starting the transition to PI and building upon my own mistakes and advice from multiple generous and fantastic mentors and colleagues, I have attempted this Career Article published at @ImmunolCellBiol
https://t.co/daE93E42Yr
A number of new studies on gasdermin were published recently. @broz_lab and I put together a review to summarise and discuss our current understanding of gasdermins during cell death and inflammation.
https://t.co/j2ApEYIfp9
I'm very proud to have co-authored this review on antibodies and infection with my twitterless PhD student Tyron Esposito, @TheWellsLab and @HendersonLab. Please check it out 👇
Mechanisms of antibody-dependent enhancement of infectious disease | Nature Reviews Immunology
The first paper from the Chen lab is out! Congrats
@seejie_yow on dissecting the cell type-specific requirements for Yersinia-induced pyroptosis in neutrophils and macrophages! https://t.co/ljYAov6A7l
@LabListon The reality is, as much as I would love to network with the highest ranking members in any department, they are often too popular and busy to entertain a small-fry grad student.
Becoming a new PI is hard but is made 100% easier when you're surrounded by wonderful colleges. Never walk alone.
My amazing colleague @dave_boucher and I just published our first work together ❤️
#inflammasomes#epithelial innate immunity @YBRI_UoY
https://t.co/I8INsHQBau
Research highlight: @jazzy_yup, @S_Emming & Prof Kate Schroder @inflammasomelab comment on work from Zhang et al. providing key insight into regulatory mechanisms governing NLRP1 activation and potential for structure-based anti-inflammatory drug design https://t.co/pjOTkl9xUj
I once saw someone refer to their PBMC ficoll process taking 2.5 hrs so I want to put our lab's SOP out there. Saves tonnes of ⏱ without compromising quality 👌
Just pop and drop those pipettes of ficoll 😎
The HIV epidemic 40 years on
https://t.co/MssbIaOvUF
@LindaGailBekker highlights the progress that has been made over the past 40 years since the discovery of HIV, and discusses the commitment needed to end the HIV/AIDS epidemic as well as ongoing challenges.
Our latest work by @michaelgeeson and @jeffreychsiao shows that NLRP1 associates with TRX1 using a transient disulfide bond. Their discovery showcases the predictive power of AlphaFold-Multimer! https://t.co/s6X7GJ09Ur
STING is a membrane channel.
Findings help explain why STING has all those transmembrane domains, a question that has puzzled many (including me) for years. Kudos to Hacohen, Irvine and Bingxu Liu on this interesting discovery.
@BingxuL@MIT
https://t.co/mUloW50Jd1